"Is the Janssen deal simply conditional on successfully filing patent protection?"
Wonderful question. Phylogica has identified a panel of FPPs. Does each one of those FPPs require specific patent protection or are they covered under an existing class patent already held by Phylogica?
Enumerate,
You appear to suggest that formal patent acceptance of the FPPs for 'therapeutic use' is required.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 40248 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |